Aleafia Health Inc (AH.CA) Forecast, Price Target & Analyst Ratings

TSX:AHCA01444Q1046

Current stock price

0.02 CAD
0 (0%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Aleafia Health Inc (AH.CA).

Forecast Snapshot

Consensus Price Target

Price Target
CA$0.15
+ 665.00% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
Period
Q4 / 2024
EPS Estimate
-CA$0.04
Revenue Estimate
19.776M

ChartMill Buy Consensus

Rating
40.00%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
CA$0.15
Upside
+ 665.00%
From current price of CA$0.02 to mean target of CA$0.15, Based on 8 analyst forecasts
Low
CA$0.15
Median
CA$0.15
High
CA$0.16

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for AH.CA. The average price target is 0.15 CAD. This implies a price increase of 665% is expected in the next year compared to the current price of 0.02.

Analyst Ratings & History

Current Analyst Ratings

AH Current Analyst RatingAH Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

AH Historical Analyst RatingsAH Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
40.00%
AH.CA was analyzed by 8 analysts. The buy percentage consensus is at 40. So analysts seem to be rather negative about AH.CA.
In the previous month the buy percentage consensus was at a similar level.
AH.CA was analyzed by 8 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2022-02-16Raymond James CapitalInitiate Market Perform
2022-02-14Raymond James FinancialDowngrade Market Perform
2021-11-12RaymondJamesFinancialDowngrade Market Perform
2021-08-11Raymond James FinancialDowngrade Outperform
2021-06-17Raymond James FinancialInitiate Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A
Period
Q4 / 2024
EPS Estimate
-CA$0.04
Revenue Estimate
19.776M
Revenue Q2Q
110.52%
EPS Q2Q
-300.00%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2021 2022 2023 2024 2025
Revenue
YoY % growth
AH.CA revenue by date.AH.CA revenue by date.
44.54M
172.42%
36.08M
-18.99%
42.847M
18.76%
76.426M
78.37%
87.653M
14.69%
EBITDA
YoY % growth
AH.CA ebitda by date.AH.CA ebitda by date.
-37.34M
-106.53%
-54.91M
-47.05%
-11.693M
78.71%
15.999M
236.83%
8.446M
-47.21%
EBIT
YoY % growth
AH.CA ebit by date.AH.CA ebit by date.
-47.5M
-98.00%
-65.19M
-37.24%
-18.258M
71.99%
-4.326M
76.31%
927K
121.43%
Operating Margin
AH.CA operating margin by date.AH.CA operating margin by date.
-106.65%-180.68%-42.61%-5.66%1.06%
EPS
YoY % growth
AH.CA eps by date.AH.CA eps by date.
-0.27
-482.52%
N/A
75.20%
N/A
23.08%
-0.03
40.00%
-0.03

All data in CAD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 24
EPS
Q2Q % growth
-0.04
-300.00%
Revenue
Q2Q % growth
19.776M
110.52%
EBITDA
Q2Q % growth
N/A
EBIT
Q2Q % growth
-309K
95.96%

All data in CAD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

AH.CA Yearly Revenue VS EstimatesAH.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
AH.CA Yearly EPS VS EstimatesAH.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 -0.05 -0.1 -0.15 -0.2 -0.25

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A

Aleafia Health Inc / AH.CA Forecast FAQ

What is the price target for AH stock?

8 analysts have analysed AH.CA and the average price target is 0.15 CAD. This implies a price increase of 665% is expected in the next year compared to the current price of 0.02.

What are the consensus estimates for AH stock next earnings?

The consensus EPS estimate for the next earnings of Aleafia Health Inc (AH.CA) is -0.04 CAD and the consensus revenue estimate is 19.78M CAD.

How many analysts have analysed Aleafia Health Inc (AH.CA)?

The number of analysts covering Aleafia Health Inc (AH.CA) is 8.